⌘K

Login Start Free

Home/Filings/4/0000905148-24-000762

4//SEC Filing

Gamelin Erick 4

Accession 0000905148-24-000762

CIK 0001781174other

View on SEC.gov Company Profile

Filed

Feb 15, 7:00 PM ET

Accepted

Feb 16, 5:10 PM ET

Size

4.4 KB

Accession

0000905148-24-000762

Insider Transaction Report

Form 4

Period: 2024-02-14

Acrivon Therapeutics, Inc.ACRV

Chief Development Officer

Transactions

Tax Payment
Common Stock
2024-02-14$3.40/sh−468$1,591→ 18,167 total

Footnotes (1)

[F1]Shares withheld by the Issuer to satisfy the mandatory tax withholding requirement upon vesting of restricted stock units.

Documents

1 file

4
form4.xmlPrimary

Issuer

Acrivon Therapeutics, Inc.

CIK 0001781174

Entity typeother

Related Parties

1

filerCIK 0001950551

Filing Metadata

Form type: 4
Filed: Feb 15, 7:00 PM ET
Accepted: Feb 16, 5:10 PM ET
Size: 4.4 KB

View on SEC.gov